AstraZeneca's late-stage U.S. study of COVID-19 vaccine still on hold - Azar
Published
Published
US Health and Human Services Secretary Alex Azar said on Wednesday that the US trial of AstraZeneca PLC's Covid-19 vaccine remains..
The top U.S. infectious disease expert said AstraZeneca’s suspension of final testing of its COVID-19 vaccine candidate shows..